Role of accelerated fractionated irradiation for supraglottic carcinoma: Assessment of results

Cancer Journal from Scientific American

Volumn 3, Issue 2, 1997, Pages 88-91

  Wang, C C ^a   Nakfoor, Bruce M ^a   Spiro, Ira J ^a   Martins, Patricia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

complications; local control; Radiation; regional control; relapse free survival; supraglottis

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EDEMA; FEMALE; GLOTTIS; HUMANS; LARYNGEAL DISEASES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; STOMATITIS; VOICE QUALITY;

EID: 0030899080     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wang CC, Suit HD, Blitzer PH. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1985; 12:3-7.
2. American Joint Committee on Cancer: Manual for Staging of Cancer (4th ed). Philadelphia: Lippincott, 1992:39-41.
3. Kaplan ES, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
4. Fletcher GH, Jesse RH, Lindberg RD et al. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx. Am J Roentgenol 1970;108:19.
5. Harwood AR, Beale FA, Curnmings BJ et al. Supraglottic laryngeal carcinoma: an analysis of dose-time volume factors in 410 patients. Int J Radiat Oncol Biol Phys. 1983;9:311-319.
6. Wang CC. Megavoltage radiation therapy for supraglottic carcinoma result of treatment. Radiology 1973;109:183-186.
7. Wang CC, Schulz MD, Miller D. Combined radiation therapy and surgery for carcinoma of the supraglottis and pyriform sinus. Am J Surg 1972;124:551.
8. Flynn MB, Jesse RH, Lindberg RD. Surgery and irradiation in the treatment of squamous cell cancer of the supraglottic larynx. Am J Surg 1972;124:477-481.
9. Fu KK, Eisenberg L, Dedo HH et al. Results of integrated management of supraglottic carcinoma. Cancer 1977;40:2874-2881.
10. Mendenhall WM, Parsons JT, Stringer SP et al. Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery. Head Neck 1990;12:204-209.
11. Parsons JT, Mendenhall WM, Stringer SP et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck 1993;15:87-96.
12. Wendt CD, Peters LJ, Ang KK et al. Hyperfractionated radiotherapy in the treatment of squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1989;17:1057-1062.
13. Garden AS, Morrison WH, Ang KK et al. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schemes. Int J Radiat Oncol Biol Phys 1994;31:493-502.
14. Wang CC, Effird JT. Does prolonged treatment time adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 1994;29:657-670.
15. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
16. Horiot JC, LeFlur R, N'Guyen T et al. Hyperfractionated versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy. Radiother Oncol 1992;25:231-241.
17. Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L et al. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988;27:147-152.
18. Maciejewski B, Preuss-Bayer G, Trott KR, The influence of the number of fractions and of overall treatment time on local control and late complications rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983;9:321-328.
19. Slevin NJ, Hendry JH, Roberts SA et al. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992;24:215-220.